We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-15.19%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.4B
AUM Growth
-$2.53B
Cap. Flow
-$239M
Cap. Flow %
-2.3%
Top 10 Hldgs %
18.85%
Holding
2,568
New
165
Increased
997
Reduced
1,065
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 7.95%
2 Healthcare 4.79%
3 Financials 4.53%
4 Consumer Discretionary 3.82%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORAN
2501
DELISTED
Orange
ORAN
-13,384
Closed -$195K
SIX
2502
DELISTED
Six Flags Entertainment Corp.
SIX
-17,914
Closed -$808K
MDC
2503
DELISTED
M.D.C. Holdings, Inc.
MDC
-6,970
Closed -$246K
ORTX
2504
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-2,230
Closed -$307K
ICPT
2505
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-5,310
Closed -$658K
BKI
2506
DELISTED
Black Knight, Inc. Common Stock
BKI
-4,360
Closed -$281K
AJRD
2507
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-5,713
Closed -$261K
RNDM
2508
DELISTED
First Trust Developed International Equity Select ETF
RNDM
-5,376
Closed -$281K
NIB
2509
DELISTED
iPath Bloomberg Cocoa Subindex Total Return ETN due June 24, 2038
NIB
-110,899
Closed -$3.25M
AUD
2510
DELISTED
Audacy, Inc.
AUD
-12,117
Closed -$56K
EXD
2511
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
-12,964
Closed -$133K
ATCO
2512
DELISTED
Atlas Corp.
ATCO
-13,327
Closed -$189K
LCI
2513
DELISTED
Lannett Company, Inc.
LCI
-3,172
Closed -$112K
RSX
2514
DELISTED
VanEck Russia ETF
RSX
-22,608
Closed -$565K
Y
2515
DELISTED
Alleghany Corp
Y
-1,052
Closed -$841K
WBII
2516
DELISTED
WBI BullBear Global Income ETF
WBII
-8,101
Closed -$207K
MTOR
2517
DELISTED
MERITOR, Inc.
MTOR
-14,306
Closed -$375K
CDK
2518
DELISTED
CDK Global, Inc.
CDK
-5,947
Closed -$325K
HBP
2519
DELISTED
Huttig Building Products, Inc.
HBP
-15,671
Closed -$24K
RRD
2520
DELISTED
RR Donnelley & Sons Co.
RRD
-10,586
Closed -$42K
TCP
2521
DELISTED
TC Pipelines LP
TCP
-5,712
Closed -$242K
EV
2522
DELISTED
Eaton Vance Corp.
EV
-4,758
Closed -$222K
CXO
2523
DELISTED
CONCHO RESOURCES INC.
CXO
-4,026
Closed -$353K
SRE.PRA
2524
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
-2,654
Closed -$319K
HSBC.PRA
2525
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
-15,263
Closed -$410K

Similar funds

Cambridge Investment Research Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Cambridge Investment Research Advisors held 2,568 positions worth $10.4B, down 20% from $13B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors's Q1 2020 filing shows 165 new, 997 increased, 1,065 reduced and 296 closed positions. Its largest new stake was iShares GNMA Bond ETF: 171,895 shares worth $8.87M. The largest sale was Vanguard S&P 500 ETF, an estimated $94M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Financials.

  • Cambridge Investment Research Advisors's largest Q1 2020 buy was iShares GNMA Bond ETF: 171,895 shares worth $8.87M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q1 2020, an estimated $80.7M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $94M.
  • Cambridge Investment Research Advisors fully exited Schwab Fundamental International Small Company Index ETF in Q1 2020, selling an estimated $10.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $10.4B portfolio in Q1 2020.
  • Cambridge Investment Research Advisors opened 165 new positions and closed 296 in Q1 2020.
  • Cambridge Investment Research Advisors's portfolio value fell 20% quarter-over-quarter to $10.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2020, filed 8 May 2020.